Read next
AI-Driven Drug Discovery Pipelines Progress to Phase II Clinical Trials
Biopharmaceutical firms report accelerated timelines in candidate identification using advanced machine learning models.
Continuous Glucose Monitors Expand Beyond Diabetes into Clinical Preventative Care
Regulatory clearances and declining sensor unit costs are accelerating adoption in metabolic monitoring programs.
GLP-1 Supply Expansion Reconfigures Pharmaceutical Capex Allocation
Pharmaceutical majors reallocate capital toward fill-finish capacity to clear persistent inventory bottlenecks.
What Actually Helps With Back Pain From Sitting
The advice about perfect posture has weaker evidence than the advice to move.
Targeted mRNA Platforms Focus on Autoimmune Conditions in Phase II Trials
Clinical trial data reveals promising results for antigen-specific mRNA therapies designed to suppress autoimmune responses without global immunosuppression.
Clinical Trials Integrate Continuous Biomarker Monitoring for Precision Oncology
Pharmaceutical research organizations are deploying real-time wearable sensors to improve oncology trial protocol accuracy.